-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia
Meenakshi Devidas, James R Anderson
Clinical Trail Methodology: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Hypocretin receptor antagonists for insomnia: rationale and clinical data
Chad Ruoff, Christian Guilleminault
Review: Clinical Trail Outcomes: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation
-
Where now for obesity research?
George A Bray
Editorial: Clinical Investigation